Literature DB >> 34405831

Dual Efficacy of Upadacitinib in 2 Patients With Concomitant Severe Atopic Dermatitis and Alopecia Areata.

Alessio Gambardella, Gaetano Licata, Giulia Calabrese, Alina De Rosa, Roberto Alfano, Giuseppe Argenziano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34405831     DOI： 10.1097/DER.0000000000000780

Source DB:  PubMed          Journal:  Dermatitis        ISSN： 1710-3568            Impact factor:   4.845


× No keyword cloud information.
  3 in total

Review 1.  [Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?]

Authors:  Stephan Traidl; Annice Heratizadeh
Journal:  Dermatologie (Heidelb)       Date:  2022-06-01

Review 2.  An overview of JAK/STAT pathways and JAK inhibition in alopecia areata.

Authors:  Maddison Lensing; Ali Jabbari
Journal:  Front Immunol       Date:  2022-08-30       Impact factor: 8.786

3.  Upadacitinib improved alopecia areata in a patient with atopic dermatitis: A case report.

Authors:  Mariateresa Cantelli; Fabrizio Martora; Cataldo Patruno; Paola Nappa; Gabriella Fabbrocini; Maddalena Napolitano
Journal:  Dermatol Ther       Date:  2022-02-10       Impact factor: 3.858
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.